These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37818778)

  • 1. Electrochemical Modification of Polypeptides at Selenocysteine.
    Mackay AS; Maxwell JWC; Bedding MJ; Kulkarni SS; Byrne SA; Kambanis L; Popescu MV; Paton RS; Malins LR; Ashhurst AS; Corcilius L; Payne RJ
    Angew Chem Int Ed Engl; 2023 Dec; 62(50):e202313037. PubMed ID: 37818778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-selective photocatalytic functionalization of peptides and proteins at selenocysteine.
    Dowman LJ; Kulkarni SS; Alegre-Requena JV; Giltrap AM; Norman AR; Sharma A; Gallegos LC; Mackay AS; Welegedara AP; Watson EE; van Raad D; Niederacher G; Huhmann S; Proschogo N; Patel K; Larance M; Becker CFW; Mackay JP; Lakhwani G; Huber T; Paton RS; Payne RJ
    Nat Commun; 2022 Nov; 13(1):6885. PubMed ID: 36371402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins.
    Cohen DT; Zhang C; Fadzen CM; Mijalis AJ; Hie L; Johnson KD; Shriver Z; Plante O; Miller SJ; Buchwald SL; Pentelute BL
    Nat Chem; 2019 Jan; 11(1):78-85. PubMed ID: 30397320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Diverse Helix-Constrained Peptides Using Selenocysteine Crosslinking.
    Dantas de Araujo A; Perry SR; Fairlie DP
    Org Lett; 2018 Mar; 20(5):1453-1456. PubMed ID: 29461066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Umpolung Approach for the Chemoselective Arylation of Selenocysteine in Unprotected Peptides.
    Cohen DT; Zhang C; Pentelute BL; Buchwald SL
    J Am Chem Soc; 2015 Aug; 137(31):9784-7. PubMed ID: 26225900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable and Potent Selenomab-Drug Conjugates.
    Li X; Nelson CG; Nair RR; Hazlehurst L; Moroni T; Martinez-Acedo P; Nanna AR; Hymel D; Burke TR; Rader C
    Cell Chem Biol; 2017 Apr; 24(4):433-442.e6. PubMed ID: 28330604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoisotopic mass determination algorithm for selenocysteine-containing polypeptides from mass spectrometric data based on theoretical modeling of isotopic peak intensity ratios.
    Kim JW; Lee S; Park K; Na S; Paek E; Park HS; Park H; Lee KJ; Jeong J; Kim HY
    J Proteome Res; 2012 Sep; 11(9):4488-98. PubMed ID: 22779694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoselective Copper-Mediated Modification of Selenocysteines in Peptides and Proteins.
    Zhao Z; Shimon D; Metanis N
    J Am Chem Soc; 2021 Aug; 143(32):12817-12824. PubMed ID: 34346673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide ligation chemistry at selenol amino acids.
    Malins LR; Mitchell NJ; Payne RJ
    J Pept Sci; 2014 Feb; 20(2):64-77. PubMed ID: 24285588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a selenocysteine-containing peptide by native chemical ligation.
    Gieselman MD; Xie L; van Der Donk WA
    Org Lett; 2001 May; 3(9):1331-4. PubMed ID: 11348227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of peptide thioester formation via N→Se acyl transfer.
    Adams AL; Macmillan D
    J Pept Sci; 2013 Feb; 19(2):65-73. PubMed ID: 23297044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lyase-dependent attenuation of cisplatin-mediated toxicity by selenocysteine Se-conjugates in renal tubular cell lines.
    Rooseboom M; Schaaf G; Commandeur JN; Vermeulen NP; Fink-Gremmels J
    J Pharmacol Exp Ther; 2002 Jun; 301(3):884-92. PubMed ID: 12023515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the 21st amino acid-purifying and labeling proteins by selenolate targeting.
    Johansson L; Chen C; Thorell JO; Fredriksson A; Stone-Elander S; Gafvelin G; Arnér ES
    Nat Methods; 2004 Oct; 1(1):61-6. PubMed ID: 15782154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenocysteine containing analogues of Atx1-based peptides protect cells from copper ion toxicity.
    Shoshan MS; Lehman Y; Goch W; Bal W; Tshuva EY; Metanis N
    Org Biomol Chem; 2016 Aug; 14(29):6979-84. PubMed ID: 27349676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivation of chemopreventive selenocysteine Se-conjugates and related amino acids by amino acid oxidases novel route of metabolism of selenoamino acids.
    Rooseboom M; Vermeulen NP; van Hemert N; Commandeur JN
    Chem Res Toxicol; 2001 Aug; 14(8):996-1005. PubMed ID: 11511173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody conjugation via one and two C-terminal selenocysteines.
    Li X; Yang J; Rader C
    Methods; 2014 Jan; 65(1):133-8. PubMed ID: 23756202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 2,2'-dithiobis(5-nitropyridine) (DTNP) for deprotection and diselenide formation in protected selenocysteine-containing peptides.
    Schroll AL; Hondal RJ; Flemer S
    J Pept Sci; 2012 Mar; 18(3):155-62. PubMed ID: 22249911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds.
    Besse D; Moroder L
    J Pept Sci; 1997; 3(6):442-53. PubMed ID: 9467972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemistry for the Chemoselective Modification of Peptides and Proteins.
    Mackay AS; Payne RJ; Malins LR
    J Am Chem Soc; 2022 Jan; 144(1):23-41. PubMed ID: 34968405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.